Belatacept Pharmacokinetic Trial in Renal Transplantation
NCT00578448
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Transplantation
Interventions
DRUG:
Belatacept
Sponsor
Bristol-Myers Squibb